Clinical Trials Browser

OTHER × Interventional × Hypoalphalipoproteinemias × Clear all

NCT04776889 2021-03-02

The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients

Phase 4 Completed

Prostatic Neoplasms, Hypoalphalipoproteinemias